March 13, 2013 - Volume 27 - Issue 5
pp: 675-855
Subscribe to eTOC

Drug–drug interactions between antiretrovirals and drugs used in the management of neglected tropical diseases: important considerations in the WHO 2020 Roadmap and London...

Seden, Kay; Khoo, Saye; Back, David; More

AIDS . 27(5):675-686, March 13, 2013.



The pharmacokinetics, safety and efficacy of tenofovir and emtricitabine in HIV-1-infected pregnant women

Colbers, Angela P.H.; Hawkins, David A.; Gingelmaier, Andrea; More

AIDS . 27(5):739-748, March 13, 2013.

A novel pharmacokinetic approach to predict virologic failure in HIV-1-infected paediatric patients

Bouazza, Naïm; Tréluyer, Jean-Marc; Msellati, Philippe; More

AIDS . 27(5):761-768, March 13, 2013.

Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination antiretroviral treatment

Lapadula, Giuseppe; Cozzi-Lepri, Alessandro; Marchetti, Giulia; More

AIDS . 27(5):769-779, March 13, 2013.

Concise Communication


Joint effects of alcohol consumption and high-risk sexual behavior on HIV seroconversion among men who have sex with men

Sander, Petra M.; Cole, Stephen R.; Stall, Ronald D.; More

AIDS . 27(5):815-823, March 13, 2013.

CONCISE COMMUNICATION

Evidence of an explosive epidemic of HIV infection in a cohort of men who have sex with men in Thailand

van Griensven, Frits; Thienkrua, Warunee; McNicholl, Janet; More

AIDS . 27(5):825-832, March 13, 2013.




Once-daily darunavir/ritonavir and abacavir/lamivudine versus tenofovir/emtricitabine for treatment-naïve patients with a baseline viral load of more than 100 000 copies/ml

Nishijima, Takeshi; Komatsu, Hirokazu; Teruya, Katsuji; More

AIDS . 27(5):839-842, March 13, 2013.

Poor outcome of HIV-infected patients with plasmablastic lymphoma: results from the German AIDS-related lymphoma cohort study

Schommers, Philipp; Wyen, Christoph; Hentrich, Marcus; More

AIDS . 27(5):842-845, March 13, 2013.